P
Pliant Therapeutics, Inc. (PLRX)
NMS – Real Time Price. Currency in USD
1.18
-0.02 (-1.67%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.18
-0.02 (-1.67%)
At close: May 12, 2026, 4:00 PM EDT
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company’s lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of αvß8 and αvß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
| Name | Position |
|---|---|
| Dr. Bernard Coulie M.B.A., M.D., Ph.D. | President, CEO & Director |
| Dr. Keith Lamont Cummings M.B.A., M.D. | Chief Financial Officer |
| Dr. Rik Derynck Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
| Monica Sandberg Ph.D. | Vice President, Regulatory & Compliance |
| Mr. Christopher S. Keenan | Vice President of Investor Relations & Corporate Communications |
| Mr. Dean Sheppard M.D. | Scientific Founder & Member of Scientific Advisory Board |
| Mr. Hal Chapman M.D. | Scientific Founder & Member of Scientific Advisory Board |
| Ms. Delphine Imbert Ph.D. | Chief Technical Officer |
| Ms. Lily Cheung | Chief Human Resources Officer |
| Ms. Minnie Kuo | Chief Operating Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-22 | DEFA14A | plrx2026defa14a.htm |
| 2026-04-17 | 8-K | plrx-20260414.htm |
| 2026-04-02 | CORRESP | filename1.htm |
| 2026-03-30 | S-3 | d130516ds3.htm |
| 2026-03-11 | 8-K | plrx-20260311.htm |
| 2026-03-11 | 10-K | plrx-20251231.htm |
| 2026-03-03 | 8-K | plrx-20260303.htm |
| 2025-12-16 | 8-K | plrx-20251210.htm |
| 2025-12-08 | 8-K | plrx-20251202.htm |
| 2025-11-06 | 10-Q | plrx-20250930.htm |